Results for tag: "Dapagliflozin Metformin"

Dapagliflozin Metformin is a combination drug used to treat type 2 diabetes. It is a combination of two drugs, dapagliflozin and metformin, which work together to reduce blood sugar levels. Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, which helps the body remove excess glucose from the blood. Metformin is a biguanide, which helps the body respond better to insulin and reduce the amount of glucose produced by the liver. Together, these two drugs can help improve glycemic control and reduce the risk of long-term complications associated with diabetes. The Dapagliflozin Metformin market is part of the larger Endocrine and Metabolic Disorders Drugs market. This market includes a variety of drugs used to treat endocrine and metabolic disorders, such as diabetes, thyroid disorders, and obesity. These drugs are used to help manage symptoms and reduce the risk of long-term complications associated with these conditions. Some companies in the Dapagliflozin Metformin market include AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck, and Novo Nordisk. Show Less Read more